What is Chronic Inflammatory Response Syndrome (CIRS)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 27, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Chronic Inflammatory Response Syndrome (CIRS): Definition, Diagnosis, and Management

Chronic Inflammatory Response Syndrome (CIRS) is a multisystem, multi-symptom condition characterized by innate immune dysregulation following exposure to biotoxins, most commonly from water-damaged buildings, that affects genetically susceptible individuals. 1

Pathophysiology and Causes

  • CIRS develops when environmental biotoxin exposure triggers chronic inflammation in genetically predisposed individuals, particularly those with specific HLA-DR/DQ haplotypes 2
  • The most common trigger is exposure to mycotoxins from water-damaged buildings containing toxic molds like Stachybotrys chartarum 2, 3
  • The condition represents a failure of the normal inflammatory response to resolve, leading to persistent immune dysregulation 1
  • Unlike acute inflammatory responses that resolve with pathogen elimination, CIRS involves ongoing inflammation despite removal from the exposure source 3

Clinical Presentation

  • CIRS manifests as a complex multisystem disorder with symptoms affecting multiple organ systems simultaneously 1
  • Common symptoms include:
    • Severe fatigue and post-exertional malaise 2, 4
    • Cognitive impairments (brain fog, memory problems, difficulty concentrating) 4
    • Respiratory issues (similar to chronic rhinosinusitis) 5
    • Gastrointestinal disturbances (can mimic inflammatory bowel conditions) 2
    • Neurological symptoms (headaches, numbness, tingling) 4
    • Musculoskeletal pain 3
    • Temperature regulation problems 6

Diagnostic Approach

  • Diagnosis requires a comprehensive assessment including:
    • Detailed exposure history focusing on water-damaged buildings 3
    • HLA-DR/DQ genetic testing to identify susceptible haplotypes 2
    • Biomarker testing including TGF-beta, MMP-9, and vasoactive intestinal peptide (VIP) levels 2, 4
    • Visual contrast sensitivity (VCS) testing, which is often abnormal in CIRS patients 4
    • Urine mycotoxin panel to identify specific biotoxin exposures 2
    • Ruling out other conditions with overlapping symptoms 3

Treatment Protocol

  • The most documented effective treatment approach is the Shoemaker Protocol, which includes: 1
    • Removal from biotoxin exposure source as the first critical step 2, 3
    • Binding agents to help eliminate circulating biotoxins 1
    • Addressing VIP deficiency with replacement therapy when indicated 2
    • Treating co-infections and addressing dental sources of inflammation when present 2
    • Implementing mind-body interventions to help modulate the stress response 2

Emerging Treatments

  • Low-pressure hyperbaric oxygen therapy (HBOT) shows promise as a potential treatment:
    • A case study demonstrated resolution of symptoms, normalization of visual contrast sensitivity, and reduction in inflammatory biomarkers after 40 HBOT sessions 4
    • HBOT appears to modulate systemic inflammation and improve neurocognitive outcomes in CIRS patients 4

Differential Diagnosis

  • CIRS is frequently misdiagnosed as:
    • Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) 1
    • Mast Cell Activation Syndrome 3
    • Chronic rhinosinusitis, particularly with type 2 inflammation 5
    • Chronic Lyme disease or other tick-borne illnesses 3
    • Fibromyalgia 3

Clinical Pitfalls and Considerations

  • CIRS remains underrecognized and underdiagnosed despite potentially affecting up to 25% of the population 1
  • Failure to identify and remove the source of biotoxin exposure will result in continued symptoms despite treatment 2, 3
  • Standard laboratory testing may not reveal abnormalities; specialized biomarker testing is often required 2
  • Genetic susceptibility plays a crucial role - not everyone exposed to water-damaged buildings will develop CIRS 2
  • Treatment outcomes are superior when the condition is correctly identified as CIRS rather than being misdiagnosed as ME/CFS 1

Prognosis

  • With proper identification of biotoxin sources, removal from exposure, and appropriate treatment, many patients can experience significant symptom improvement 2, 1
  • Case reports document complete resolution of symptoms, normalization of biomarkers, and return to normal functioning following comprehensive treatment 2, 4
  • Without proper diagnosis and treatment, CIRS can lead to persistent debilitating symptoms affecting quality of life 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.